Cis-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer

The present invention provides MDM2 inhibitor compounds of Formula (I), or the pharmaceutically acceptable salts thereof, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharma...

Full description

Saved in:
Bibliographic Details
Main Authors Yan, Xuelei, Beck, Hilary Plake, Olson, Steven H, Fox, Brian M, Julian, Lisa D, Degraffenreid, Michael R, Roveto, Philip M, Bartberger, Michael D, Sun, Daqing, Gonzalez Lopez De Turiso, Felix, Medina, Julio C, Rew, Yosup, Kayser, Frank
Format Patent
LanguageEnglish
Published 06.09.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides MDM2 inhibitor compounds of Formula (I), or the pharmaceutically acceptable salts thereof, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
AbstractList The present invention provides MDM2 inhibitor compounds of Formula (I), or the pharmaceutically acceptable salts thereof, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
Author Sun, Daqing
Yan, Xuelei
Beck, Hilary Plake
Degraffenreid, Michael R
Medina, Julio C
Gonzalez Lopez De Turiso, Felix
Kayser, Frank
Bartberger, Michael D
Julian, Lisa D
Rew, Yosup
Fox, Brian M
Olson, Steven H
Roveto, Philip M
Author_xml – fullname: Yan, Xuelei
– fullname: Beck, Hilary Plake
– fullname: Olson, Steven H
– fullname: Fox, Brian M
– fullname: Julian, Lisa D
– fullname: Degraffenreid, Michael R
– fullname: Roveto, Philip M
– fullname: Bartberger, Michael D
– fullname: Sun, Daqing
– fullname: Gonzalez Lopez De Turiso, Felix
– fullname: Medina, Julio C
– fullname: Rew, Yosup
– fullname: Kayser, Frank
BookMark eNqNyj0KAjEQQOEUWvh3hylsFzZREUuJis1War3E7IQENjMhifdXwQNYPXh8czEhJpyJmw6liZyT5zF8FxgagKvHDJZj4hcNBUyB7tQpCOTDM1TOBRxn-CioGU2NSBXYgTVkMS_F1Jmx4OrXhVhfznd9bTBxjyUZi4S1Pz5UK7dKHtr9Tmu5-ZO9AanbOwE
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2014219075CC1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2014219075CC13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:12:38 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2014219075CC13
Notes Application Number: AU20140219075
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180906&DB=EPODOC&CC=AU&NR=2014219075C1
ParticipantIDs epo_espacenet_AU2014219075CC1
PublicationCentury 2000
PublicationDate 20180906
PublicationDateYYYYMMDD 2018-09-06
PublicationDate_xml – month: 09
  year: 2018
  text: 20180906
  day: 06
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies AMGEN INC
RelatedCompanies_xml – name: AMGEN INC
Score 3.1601338
Snippet The present invention provides MDM2 inhibitor compounds of Formula (I), or the pharmaceutically acceptable salts thereof, wherein the variables are defined...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Cis-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180906&DB=EPODOC&locale=&CC=AU&NR=2014219075C1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1NT4NAEJ001ag3rRq_avbQcCOCLF-HxtgF0pjQNtqa3hqWhUhioCkY_76zG1p70hvZJQu8zTDzYGYewABdkG9x09IFMmudejTXeWrmuuMK4fqpTw0l3xZPnPGCviztZQc-t7Uwqk_ot2qOiBaVor036n29_v2IFajcyvqBFzhUPUXzYaC17Fg2ozIcLRgNw9k0mDKNMWSS2uRVzlE0TnSQDLnSgQykZaf98H0k61LW-04lOoXDGa5XNmfQycoeHLOt9loPjuL2lzcettZXn8MbK5CYVoiMVNqpyowkpSCqhIrI1HCpkFSTpCZxED-SovwoeCHFdAgGpgTPIrusclLlJJX7vbmAQRTO2VjHu1vtwFg9L_YehZnWJXTlBa-A-IlHM59nrnA9agubJ4YpOEKeC4yBrOwa-n8udfPP_C2cSIRVgpVzB91m85X10SM3_F4B-QMmRo9A
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1NT4NAEJ001VhvWjV-VffQcCMWWb4OjbFLm6qlbbQ1vTUsC5HEQFMw_n1nN7T2pDeySxZ4m2Hmwcw8gDa6IM_khqkLZNY6dWmi88hIdNsRwvEij3aUfFswtodz-rywFjX43NTCqD6h36o5IlpUhPZeqvf16vcjlq9yK4s7nuJQ_jCYdX2tYseyGVXH1vxetz-d-BOmMYZMUhu_yjmKxokOkiFX2nNkf14ZPL33ZF3KatepDI5gf4rrZeUx1OKsCQ220V5rwkFQ_fLGw8r6ihN4YykS0xyRkUo7eRaTMBNElVARmRouFZIKEhYk8IN7kmYfKU-lmA7BwJTgWWSbVU7yhERyv9en0B70Z2yo490tt2AsH-c7j8IM8wzq8oLnQLzQpbHHY0c4LrWExcOOIThCngiMgcz4Alp_LnX5z_wtNIazYLQcPY1fruBQoq2SrexrqJfrr7iF3rnkNwrUHwInki0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Cis-morpholinone+and+other+compounds+as+MDM2+inhibitors+for+the+treatment+of+cancer&rft.inventor=Yan%2C+Xuelei&rft.inventor=Beck%2C+Hilary+Plake&rft.inventor=Olson%2C+Steven+H&rft.inventor=Fox%2C+Brian+M&rft.inventor=Julian%2C+Lisa+D&rft.inventor=Degraffenreid%2C+Michael+R&rft.inventor=Roveto%2C+Philip+M&rft.inventor=Bartberger%2C+Michael+D&rft.inventor=Sun%2C+Daqing&rft.inventor=Gonzalez+Lopez+De+Turiso%2C+Felix&rft.inventor=Medina%2C+Julio+C&rft.inventor=Rew%2C+Yosup&rft.inventor=Kayser%2C+Frank&rft.date=2018-09-06&rft.externalDBID=C1&rft.externalDocID=AU2014219075CC1